Product image of Navixen (Eprosartan) supplied by GNH India

Navixen

Active Ingredient:
Eprosartan
Origin:
EU

Navixen (Eprosartan)

Eprosartan, the active ingredient in Navixen, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral administration. It selectively blocks the AT1 receptor, reducing vasoconstriction and aldosterone release, and is used to manage high blood pressure in adult patients diagnosed with hypertension.

GNH India supplies Navixen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory conformity and reliable logistics for global healthcare providers. The company adheres to stringent manufacturing standards and provides comprehensive documentation for regulatory submissions.

Manufacturer / TM Owner

Viatris Healthcare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Navixen (eprosartan) acts on the renin‑angiotensin‑aldosterone system to control blood pressure.
  • Hypertension: lowers systolic and diastolic pressure in patients with essential hypertension.
  • Primary hypertension: provides sustained blood‑pressure reduction in adults with primary high‑blood‑pressure disease.
  • Elevated blood pressure: assists clinicians in achieving target blood‑pressure goals in patients with persistently high readings.

How It Works

  • Eprosartan selectively antagonizes the angiotensin II type 1 (AT1) receptor on vascular smooth‑muscle cells, adrenal gland, and renal tubular cells. By blocking this receptor, it prevents angiotensin II‑mediated vasoconstriction and aldosterone secretion, leading to vasodilation, reduced sodium and water retention, and ultimately a decrease in systemic arterial pressure.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate intensity occurring during early treatment.
  • Fatigue: general tiredness without specific cause.
  • Nausea: occasional upset stomach or urge to vomit.
  • Abdominal discomfort: mild pain or cramping in the stomach area.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat requiring immediate medical attention.
  • Hyperkalemia: elevated blood potassium levels that may cause cardiac rhythm disturbances.
  • Acute renal impairment: sudden decline in kidney function, especially in patients with pre‑existing renal disease.
  • Hepatic dysfunction: abnormal liver enzyme elevations indicating possible liver injury.
  • Severe hypotension: marked drop in blood pressure leading to fainting or shock.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor relevant parameters.

  • Renal function: assess serum creatinine and eGFR, adjust therapy if impairment is present.
  • Electrolytes: monitor potassium levels, especially when combined with potassium‑sparing agents.
  • Hepatic status: use caution in patients with severe liver disease.
  • Elderly patients: start at lower doses and observe for orthostatic symptoms.
  • Concomitant aliskiren in diabetes: avoid due to increased risk of renal complications.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Eprosartan may interact with several medicines; careful review is required.

Major Interactions (Avoid)

  • Aliskiren in diabetic patients: increased risk of renal dysfunction and hyperkalemia.
  • Dual blockade with ACE inhibitors or other ARBs: heightened risk of hypotension, renal impairment, and hyperkalemia.
  • Potassium‑sparing diuretics (e.g., spironolactone): may cause dangerous elevations in serum potassium.
  • Lithium: can raise lithium concentrations, leading to toxicity.
  • NSAIDs (e.g., ibuprofen, naproxen): may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: additive blood‑pressure lowering effect, monitor for excessive hypotension.
  • Other antihypertensives (beta‑blockers, calcium‑channel blockers): may require dose adjustments to avoid over‑lowering blood pressure.
  • CYP450 inhibitors (e.g., ketoconazole): may modestly increase eprosartan plasma levels, warranting observation.

Frequently Asked Questions

Navixen contains eprosartan, an angiotensin II receptor blocker that is prescribed to lower elevated blood pressure in adults diagnosed with hypertension. By reducing vascular resistance, it helps achieve target blood‑pressure levels and lowers the risk of cardiovascular complications associated with sustained hypertension.

Eprosartan selectively blocks the angiotensin II type 1 (AT1) receptors on blood vessels, adrenal glands, and renal tubules. This inhibition prevents angiotensin II‑induced vasoconstriction and aldosterone release, leading to vasodilation, reduced sodium and water retention, and ultimately a decrease in systemic arterial pressure.

The appropriate dose of Navixen is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and any concomitant medications. Dosage adjustments may be needed for patients with renal or hepatic impairment, and the prescriber will provide specific instructions.

The safety of eprosartan in pregnancy and lactation has not been established. It is generally advised to avoid use during pregnancy, especially in the second and third trimesters, and to discuss potential risks with a healthcare provider if breastfeeding is considered.

To place an order, submit an enquiry on the Navixen product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with ACE inhibitors, eprosartan (Navixen) offers a similar blood‑pressure‑lowering effect but is associated with a lower incidence of cough and angioedema. Unlike some older ARBs, eprosartan has a long half‑life allowing once‑daily dosing, and it does not require dose titration in most patients.

Navixen tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or extreme temperatures.

Navixen is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a full glass of water; do not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

The most serious adverse reactions include angioedema, which can cause swelling of the face, lips, tongue, or throat and requires immediate medical attention, as well as severe hyperkalemia and acute renal impairment, especially when combined with other drugs that affect kidney function or potassium balance.

Navixen is contraindicated in patients with known hypersensitivity to eprosartan or any component of the formulation, in those with severe hepatic impairment, and in individuals taking aliskiren concurrently if they have diabetes. Clinicians should also exercise caution in patients with existing renal dysfunction or elevated serum potassium.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eprosartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT